nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation
|
Oran, Betül |
|
2015 |
21 |
8 |
p. 1405-1412 8 p. |
artikel |
2 |
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors
|
Nair, Anish P. |
|
2015 |
21 |
8 |
p. 1437-1444 8 p. |
artikel |
3 |
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
|
Ciurea, Stefan O. |
|
2015 |
21 |
8 |
p. 1392-1398 7 p. |
artikel |
4 |
Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation
|
Vaughn, Jennifer E. |
|
2015 |
21 |
8 |
p. 1418-1424 7 p. |
artikel |
5 |
Donor Nucleotide-Binding Oligomerization–Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation
|
Grube, Matthias |
|
2015 |
21 |
8 |
p. 1399-1404 6 p. |
artikel |
6 |
Editorial Board
|
|
|
2015 |
21 |
8 |
p. A4- 1 p. |
artikel |
7 |
Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow
|
Docampo, Melissa D. |
|
2015 |
21 |
8 |
p. 1360-1366 7 p. |
artikel |
8 |
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen
|
Marsh, Rebecca A. |
|
2015 |
21 |
8 |
p. 1460-1470 11 p. |
artikel |
9 |
Goals for Pay for Performance in Hematopoietic Cell Transplantation: A Primer
|
LeMaistre, C. Frederick |
|
2015 |
21 |
8 |
p. 1367-1372 6 p. |
artikel |
10 |
Granulocyte Colony-Stimulating Factor Induces Osteoblast Inhibition by B Lymphocytes and Osteoclast Activation by T Lymphocytes during Hematopoietic Stem/Progenitor Cell Mobilization
|
Li, Sidan |
|
2015 |
21 |
8 |
p. 1384-1391 8 p. |
artikel |
11 |
Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients
|
Vu, Khoan |
|
2015 |
21 |
8 |
p. 1425-1430 6 p. |
artikel |
12 |
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30+ Lymphoma Patients Who Received Multiple Prior Lines of Treatment
|
Afable, Manuel |
|
2015 |
21 |
8 |
p. 1529-1531 3 p. |
artikel |
13 |
Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
|
Beaussant, Yvan |
|
2015 |
21 |
8 |
p. 1452-1459 8 p. |
artikel |
14 |
How Do Pretransplantation Peripheral Blood Counts Inform Us about Post-Transplantation Outcomes in Acute Myeloid Leukemia?
|
Walter, Roland B. |
|
2015 |
21 |
8 |
p. 1340-1342 3 p. |
artikel |
15 |
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
|
Sanchorawala, Vaishali |
|
2015 |
21 |
8 |
p. 1445-1451 7 p. |
artikel |
16 |
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|
Jenq, Robert R. |
|
2015 |
21 |
8 |
p. 1373-1383 11 p. |
artikel |
17 |
Masthead
|
|
|
2015 |
21 |
8 |
p. A2- 1 p. |
artikel |
18 |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
|
Martin, Paul J. |
|
2015 |
21 |
8 |
p. 1343-1359 17 p. |
artikel |
19 |
Officers, Directors & Board Committee Chairs
|
|
|
2015 |
21 |
8 |
p. A5- 1 p. |
artikel |
20 |
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation
|
Afrough, Aimaz |
|
2015 |
21 |
8 |
p. 1413-1417 5 p. |
artikel |
21 |
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire
|
Xavier, Erick |
|
2015 |
21 |
8 |
p. 1515-1523 9 p. |
artikel |
22 |
Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning
|
Zao, Jamie H. |
|
2015 |
21 |
8 |
p. 1471-1478 8 p. |
artikel |
23 |
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation
|
Peric, Zinaida |
|
2015 |
21 |
8 |
p. 1431-1436 6 p. |
artikel |
24 |
Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by Race
|
Clay, Alyssa |
|
2015 |
21 |
8 |
p. 1488-1494 7 p. |
artikel |
25 |
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
|
Cieri, Nicoletta |
|
2015 |
21 |
8 |
p. 1506-1514 9 p. |
artikel |
26 |
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study
|
Sorror, Mohamed L. |
|
2015 |
21 |
8 |
p. 1479-1487 9 p. |
artikel |
27 |
Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation
|
Gassas, Adam |
|
2015 |
21 |
8 |
p. 1524-1528 5 p. |
artikel |
28 |
Table of Contents
|
|
|
2015 |
21 |
8 |
p. A6-A7 nvt p. |
artikel |
29 |
Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non–Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan
|
Ikegame, Kazuhiro |
|
2015 |
21 |
8 |
p. 1495-1505 11 p. |
artikel |
30 |
Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain Amyloidosis
|
Gertz, Morie A. |
|
2015 |
21 |
8 |
p. 1339-1340 2 p. |
artikel |